(Q73504117)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9220288%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Treatment of human prostate tumors PC-3 and TSU-PR1 with standard and investigational agents in SCID mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9220288%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9220288

6 November 2024

author name string

L. Polin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9220288

6 November 2024

F. Valeriote

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9220288

6 November 2024

K. White

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9220288

6 November 2024

C. Panchapor

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9220288

6 November 2024

S. Pugh

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9220288

6 November 2024

J. Knight

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9220288

6 November 2024

P. LoRusso

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9220288

6 November 2024

M. Hussain

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9220288

6 November 2024

E. Liversidge

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9220288

6 November 2024

N. Peltier

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9220288

6 November 2024

T. Golakoti

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9220288

6 November 2024

G. Patterson

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9220288

6 November 2024

R. Moore

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9220288

6 November 2024

T. H. Corbett

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9220288

6 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9220288

6 November 2024

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9220288%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9220288

Investigational New Drugs

6 November 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9220288%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9220288%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9220288%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

99-108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9220288%20AND%20SRC:MED&resulttype=core&format=json

5-Fluorouracil containing combinations in murine tumor systems

4 November 2019

cites work

1 reference

12 December 2020

Preclinical anticancer activity of cryptophycin-8

1 reference

12 December 2020

Is the P388 murine tumor no longer adequate as a drug discovery model?

1 reference

12 December 2020

Establishment of a new prostatic carcinoma cell line (TSU-Pr1).

1 reference

12 December 2020

Taxol in advanced, hormone-refractory carcinoma of the prostate. A phase II trial of the Eastern Cooperative Oncology Group

1 reference

12 December 2020

Response of transplantable tumors of mice to anthracenedione derivatives alone and in combination with clinically useful agents

1 reference

12 December 2020

Toxicity and anticancer activity of a new triazine antifolate (NSC 127755).

1 reference

12 December 2020

Cancer Treatment Reports

7

66

1187

TH Corbett

1982

1 reference

Crossref

DOI

10.1023/A:1005856605726

https://api.crossref.org/works/10.1023/A:1005856605726

Proceedings of the American Association for Cancer Research

6 November 2024

12

35

280

CA Carter

1994

1 reference

Crossref

DOI

10.1023/A:1005856605726

https://api.crossref.org/works/10.1023/A:1005856605726